HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRI

HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRI

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRIПодробнее

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRI

Focal Therapy for #ProstateCancer: Lowest Risk of ED? | #MarkScholzMD #PCRI #AlexScholzПодробнее

Focal Therapy for #ProstateCancer: Lowest Risk of ED? | #MarkScholzMD #PCRI #AlexScholz

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRIПодробнее

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRI

The Pros and Cons of Proton Therapy | Mark Scholz, MD | PCRIПодробнее

The Pros and Cons of Proton Therapy | Mark Scholz, MD | PCRI

Tulsa Pro for Prostate Cancer | Laurence Klotz, MD, 2020 Prostate Cancer PCRI ConferenceПодробнее

Tulsa Pro for Prostate Cancer | Laurence Klotz, MD, 2020 Prostate Cancer PCRI Conference

Актуальное